CSPC Pharmaceutical Group... (CHJTF)
OTC: CHJTF
· Real-Time Price · USD
1.27
0.00 (0.00%)
At close: Aug 05, 2025, 12:35 PM
1.27
0.00%
After-hours: Aug 21, 2025, 04:00 PM EDT
CSPC Pharmaceutical Cash Flow Statement
Financials in HKD. Fiscal
year is
January - December.
| Fiscal Year | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q4 2022 | Q2 2022 | Q4 2021 | Q2 2021 |
| Period Ending | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Dec 31, 2022 | Jun 30, 2022 | Dec 31, 2021 | Jun 30, 2021 |
Net Income | 1.58B | 585.23M | 839.29M | 3.25B | 1.75B | 3.2B | 1.64B | 3.36B | 3.54B | 3.58B | 3.08B | 3.67B |
Depreciation & Amortization | n/a | n/a | n/a | 678.6M | n/a | 644.23M | n/a | 599.69M | 640.91M | 580.55M | 525.44M | 515.51M |
Stock-Based Compensation | n/a | 43.05M | 57.34M | 127.05M | 70.8M | 138.13M | 64.1M | n/a | 100.57M | n/a | n/a | n/a |
Other Working Capital | n/a | n/a | n/a | n/a | n/a | -1.23B | n/a | n/a | 1.04B | n/a | n/a | n/a |
Other Non-Cash Items | -1.58B | -628.28M | -896.63M | -2.52B | -1.82B | 3.21B | -1.7B | -1.12B | -816.51M | 2.41B | 1.58B | 274.96M |
Deferred Income Tax | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Change in Working Capital | n/a | n/a | n/a | n/a | n/a | -4.04B | n/a | n/a | 352.02M | n/a | -1.68B | n/a |
Operating Cash Flow | n/a | n/a | n/a | 1.53B | n/a | 3.14B | n/a | 1.63B | 3.81B | 5.41B | 2.45B | 3.43B |
Capital Expenditures | n/a | n/a | n/a | -697.58M | n/a | -983.05M | n/a | -1.16B | -1.6B | -1.17B | -1.33B | -794.39M |
Cash Acquisitions | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 496.21M | -45.48M | -288.27M | 75.75M | 210.62M |
Purchase of Investments | n/a | n/a | n/a | n/a | n/a | n/a | n/a | -4.5B | n/a | -6.68B | -1.93B | -4.61B |
Sales Maturities Of Investments | n/a | n/a | n/a | n/a | n/a | 647.85M | n/a | 6.64B | n/a | 1B | 4.3B | 3B |
Other Investing Acitivies | n/a | n/a | n/a | -1.59B | n/a | 67.34M | n/a | -240.48M | 405.64M | n/a | 44.87M | -29.21M |
Investing Cash Flow | n/a | n/a | n/a | -2.29B | n/a | -267.85M | n/a | 1.24B | -1.24B | -7.14B | 1.16B | -2.23B |
Debt Repayment | n/a | n/a | n/a | -85.92M | n/a | n/a | n/a | -81.99M | n/a | 320.58M | n/a | -194.43M |
Common Stock Repurchased | n/a | n/a | n/a | -379.49M | n/a | -269.23M | n/a | -226.6M | n/a | -16.64M | -318.94M | n/a |
Dividend Paid | n/a | n/a | n/a | -1.65B | n/a | -1.67B | n/a | -1.36B | -1.22B | -1.23B | -970.18M | -1.08B |
Other Financial Acitivies | n/a | n/a | n/a | -347.84M | n/a | 296.7M | n/a | 59.68M | -77.02M | -38.89M | -74.18M | -17.4M |
Financial Cash Flow | n/a | n/a | n/a | -2.46B | n/a | -1.38B | n/a | -1.6B | -1.3B | -928.55M | -1.37B | -1.29B |
Net Cash Flow | n/a | n/a | n/a | 8.05B | n/a | 1.72B | n/a | -271.85M | -8.04B | -731.43M | 1.64B | 1.07B |
Free Cash Flow | n/a | n/a | n/a | 834.08M | n/a | 2.16B | n/a | 473.8M | 2.22B | 4.24B | 1.12B | 2.64B |